DOCSLIB.ORG

Hannah Jackson Amy Skinner Jeevana Rajkumar

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hannah Jackson Amy Skinner Jeevana Rajkumar #PASSIONTOPURPOSE VIRTU A L YOUTH LE A DERSHIP SUMMIT ADAPT, EVOLVE AND LEAD IN A POST-PANDEMIC WORLD WELCOME 2 ABOUT 3 EVENT SCHEDULE 4 DAY 1 5 CONTENTS DAY 2 17 OF DAY 3 31 DAY 4 48 BLE A DAY 5 66 T I want to welcome you to the Passion to Purpose event 2021, hosted by The Duke of Edinburgh’s International Award - Canada, as part of the Canada Service Corps initiative. We hope that this forum does exactly as its title suggests: help to inspire and motivate you to turn whatever you are passionate about into something purposeful, something that helps your community, however you wish to define that term.If you are attending this conference you have expressed a desire to take on a role as a Leader in your community. This forum is designed to encourage you to identify the skills, attributes and drivers that might make you more successful in this leadership role. Successful in the sense of drawing others into your project, engaging fully with partners and others members of our wonderful civil society amd WELCOME ensuring that what you set out to achieve has real community impact. I hope you enjoy your initial experience and are able to take away from this week something that helps you build a future of which you are proud to be a part and for which you can feel responsible. Stephen De-Wint National Executive Director The Duke of Edinburgh’s International Award - Canada 2 PASSION TO PURPOSE Passion to Purpose (P2P) is a comprehensive, youth forum that is designed to foster community service through civic leadership in young Canadians. Participants from across the country have engaged in inspirational keynotes, workshops, team building exercises and activities that develop passion into action plans that can be executed within their communities. Through the P2P program and in partnership with the Federal Government, young Canadians aged 15 to 30 have the opportunity to apply for a community grant in an effort to bring the projects to life. THE DUKE OF EDINBURGH’S INTERNATIONAL AWARD The Duke of Edinburgh’s International Award (The Award) is a global program whose goal is to challenge, empower, and recognize young people between the ages of 16 and 24. From coast to coast since 1963, the Award in Canada has supported young Canadians to challenge themselves to achieve personal goals and take control of their lives and future. We reach young Canadians in all communities and give them an experiential yet supportive platform to develop the skills they need to find success in life. We are an BOUT international Award program that champions young Canadians as they become the best they can be. A CANADA SERVICE CORPS Canada Service Corps (CSC) is a Federal program piloted by the Employment Social Development Canada (ESDC). The program encourages young Canadians to get involved in their community through service opportunities, while at the same time gaining valuable skills that will benefit them in life and work. Just as important, the experience will give them a new perspective on their community and will make them better citizens. The Duke of Edinburgh’s International Award is one of the coalition partners piloting this initiative. The Canada Service Corps is currently in the process of accepting micro grant applications to assist young Canadians with their own project ideas 3 The Passion to Purpose Youth Leadership Summit will give young leaders the tools and skillsets they need to reinvigorate their passions so that they can tackle community change post the COVID-19 pandemic. PERSONAL DEVELOPMENT. BUILDING YOU! The first day focuses on rebuilding confidence in the participant's ability and skills while also discussing ways to energize oneself from COVID-19 Fatigue. Presentations and interactive workshops will revolve around working on the skills DAY 1 you may have lost touch with during quarantine/lockdown due to lack of in person interaction with others. COMMUNITY ENGAGEMENT: FINDING YOUR LIGHT! The second day builds on the skills and abilities discovered during Day 1. The sessions and workshops on Day 2 will focus on matching your skill sets and passions to workable solutions for community impact. It looks at what you can offer to your DAY 2 communities as solutions for community issues and how these solutions can be designed to fit the community's needs. BUILDING YOUR PASSION INTO A PROJECT Day 3 is all about workshops that are designed to support SCHEDULE building and developing a small-scale project for community impact. Workshop activities will focus on solution building, resource mapping, budget planning, and project timelines. DAY 3 You will use the Award's Community Action Plan workbook to focus on and map out a community engagement action plan. LEADER'S TOOLKIT: BUILDING YOUR SKILL SET Day 4 offers a hands-on workshop on communicating with confidence in the morning. Followed by option workshops for you during the afternoon. You can choose to attend the afternoon workshops or work with your groups on designing a DAY 4 sample project idea for presentation day. Workshops include topics on civic engagement, social responsibility, systemic change, project management, entrepreneurship. EVENT PRESENTATIONS We are starting the final day with an important session on Indigenous Allyship. After relearning our ways to interact, engage and support Indigenous communities, groups will deliver their project ideas to their peers. Every participant who DAY 5 attends our Virtual leadership summit will qualify for a P2P community service grant. 4 Personal Development: Building YOU! EST SESSION DESCRIPTION OPENING Welcome to the Passion to Purpose 11:30 am REMARKS Virtual Leadership Forum! We will be focusing on development, leadership, LEADERSHIP and navigating change. Alison will be speaking on DURING TIMES tips for youth to discover their inner leader and 11:45 am OF CHANGE their greatness. We will also cover building confidence to make positive changes and shape with the communities around you and the importance of Alison Springer overcoming challenges. In this Award Holder led workshop, you will be WHAT ARE jotting down the challenges that you are facing MY GENII? personally and professionally. Let's reflect on the 12:30 pm with following: 1 Melissa Tobin What do you want to overcome? How do you think you could do this? 1:15 pm NETWORKING BREAK Y We will discuss the importance of personal and DESIGNING professional skill development. Let's address the YOUR FUTURE fear of change and the fear of failure as well as 1:40 pm with adopt a “can-do” mindset and rise above the A Swish Goswami naysayers. You will learn to respond vs. react to change and uncertainty. D WHAT DO I HAVE In this workshop, we will be doing self-reflection TO OFFER? exercises about the skills you wish to further 2:30 pm with develop and how these skills can be used to Joelle McPhee service the communities you are connected to. P2P Alumni from today's session will be available to answer questions about projects, tips & tricks 3:20 pm PANEL and lessons learned while they were doing their community service projects. CLOSING Let's recap Day 1 and discuss what 3:35 pm REMARKS tomorrow will look like! HOMEWORK CLUB It's time to break out into groups to work on your 3:40pm **MANDATORY FOR sample grant projects and worksheets in your book! P2P TO GOLD** DAY ENDS AT 4:30 PM 5 ALISON SPRINGER Our speaker Alison Springer has been working with youth for over 20 years and she loves it. Living in Calgary, she is a professional youth speaker who travels all across Canada to speak to students at schools, camps, and conferences. Alison is also the Founder of Young Women of Power an organization that inspires female greatness hosting a Conference every year for teens girls this year in October. Alison was awarded the 2019 Women of Inspiration Difference Maker Award for the impact she has on youth and especially females across Canada. She coached High School basketball for so many years, but don’t be fooled, her favourite sport is actually…volleyball. Alison is passionate about helping students discover the greatness that lies within, while placing high value on people and self. Too often it is easier to see our weaknesses than our strengths, which affects how we treat each other. Get ready to view your weaknesses in a new light. MELISSA TOBIN GUESTS Melissa Tobin is an award alumni and a passionate leader from Newfoundland and Labrador. She is a cat lover, outdoor enthusiast and a third year medical student at Memorial University of Newfoundland. Melissa is a long time volunteer with Special Olympics and has held numerous leadership MELISSApositions at the localTOBIN and provincial level. She attended the first P2P Forum in 2018 and subsequently created the Sunshine Swim Camp. In 2020, she was awarded a $15,000 scale up grant from the Duke of Ed and created Sunshine Kindness Kits and the Sunshine Summer Challenge. Melissa’s is looking forward to continuing her impact by mentoring other youth to create change in their communities. 6 JOELLE MACPHEE Joelle MacPhee is a passionate product marketer who loves working on educational products that make a difference. After graduating from business school, Joelle joined her grandmother, a leading reading researcher, to launch Ooka Island, a research- based, reading company for students in grades PreK-2. During this time, Joelle applied her "try anything once" marketing philosophy and scaled Ooka Island’s user base worldwide in 36 countries. Joelle has appeared on CBC's Dragons’ Den, BNN's Disruptors Series, and the W Network's Backyard Inventors.
Load more

Recommended publications
  • The Epidemiology of COVID-19 in Canada in 2020: the Pre-Vaccine Era February 2021
    The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era February 2021 An RSC Policy Briefing The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era An RSC Policy Briefing Authors Wendy Sligl (Chair) University of Alberta David Waldner University of Alberta Jennie Johnstone University of Toronto Robyn Harrison University of Alberta Duncan Webster Dalhousie University Lynora Saxinger University of Alberta Peer Review Monitor Tom Marrie, FRSC Dalhousie University Peer Reviewers Nick Daneman University of Toronto Rob Fowler University of Toronto Srinivas Murthy The University of British Columbia David Patrick The University of British Columbia Dan Reid Dalhousie University Robert Strang Chief Medical Officer of Health, Nova Scotia Suggested citation for Policy Briefing Report: Waldner D, Harrison R, Johnstone J, Saxinger L, Webster D, Sligl W. The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era. Royal Society of Canada. 2021 Cover Art Christine De Vuono, For Your Own Good, (2020) Over the course of the pandemic, those in long term care facilities have been hit hardest with the impact of COVID-19 outbreaks. The response has been to lock down care homes and ban visitors, volunteers and even care packages, as attempts to stop the virus from entering the facility. This had the unintended, but very real consequence of isolating our most vulnerable from those who care for and love them. “For Your Own Good”, made of 100 carved figures from identical bars of soap, then placed in mason jars, which in turn are placed on shelves, allow us to look in on the miniature elderly figures, who look out at us.
    [Show full text]
  • Celebrating 100 Years
    AMERICANa CERAMICting SOCIETY ars Celebr 100 ye bulletinemerging ceramics & glass technology JUNE/JULY 2021 Student perspectives on facing uncertainty New issue inside: JUNE/JULY 2021 • VOLUME 2 • ISSUE 2 www.ceramics.org/ceramicandglassmanufacturing PREPARING FOR CONTINGENCIES HELPED COMPANIES GROW DURING THE PANDEMIC THE ROCKY ROAD BACK TO ‘LIVE’: IMPACT OF THE PANDEMIC FROM A TRADE SHOW PERSPECTIVE Materials Genome Initiative at 10 years | 2021-2022 ACerS Board members and directors When it Comes to Heat, We Sweat the Details! Your firing needs are unique. Our laboratory can run tests to So why use an “off the shelf” help identify your process kiln in your process? boundaries. Through our toll firing facility, we can At Harrop, we get it. help to further define That’s why, for over a the equipment/ century, we’ve been processing putting in the hard work combination that to design and service works best for your custom kilns. Is it harder material. And if you to do things this way? are not ready for a Yes. Is the extra effort new kiln, we can toll worth it? You bet! fire your material to help meet your At Harrop, we don’t production needs. stop there. If you aren’t sure what you Does your current need, we can help. kiln company sweat the details? www.harropusa.com 1.614.231.3621 Harrop Ad Sweat the Details ACerS Full Size w 100 logo.indd 1 5/21/20 9:33 AM contents June/July 2021 • Vol. 100 No.5 feature articles department News & Trends . 3 Materials Genome Initiative 10 years later: Spotlight .
    [Show full text]
  • Effectiveness of Bnt162b2 and Mrna-1273 Covid-19 Vaccines BMJ: First Published As 10.1136/Bmj.N1943 on 20 August 2021
    RESEARCH Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines BMJ: first published as 10.1136/bmj.n1943 on 20 August 2021. Downloaded from against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study Hannah Chung,1 Siyi He,1 Sharifa Nasreen,1 Maria E Sundaram,1,2 Sarah A Buchan,1,2,3,4 Sarah E Wilson,1,2,3,4 Branson Chen,1 Andrew Calzavara,1 Deshayne B Fell,1,5,6 Peter C Austin,1,7 Kumanan Wilson,5,8,9 Kevin L Schwartz,1,2,3 Kevin A Brown, 1,2,3 Jonathan B Gubbay,3,10 Nicole E Basta,11 Salaheddin M Mahmud,12 Christiaan H Righolt,12 Lawrence W Svenson,13,14,15,16 Shannon E MacDonald,15,17 Naveed Z Janjua,18,19 Mina Tadrous,1,20,21 Jeffrey C Kwong,1,2,3,4,22,23 on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators For numbered affiliations see ABSTRACT received at least one dose of vaccine. Among end of the article OBJECTIVE participants who tested positive, 2479 (4.7%) were Correspondence to: J Kwong To estimate the effectiveness of mRNA covid-19 admitted to hospital or died. Vaccine effectiveness [email protected] vaccines against symptomatic infection and severe against symptomatic infection observed ≥14 days (or @DrJeffKwong on Twitter ORCID 0000-0002-7820-2046) outcomes (hospital admission or death). after one dose was 60% (95% confidence interval Additional material is published DESIGN 57% to 64%), increasing from 48% (41% to 54%) at online only.
    [Show full text]
  • April 28, 2021 Update Dear Neighbours, I Would Like to Continue
    April 28, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. You’re Invited: Please send me your questions for Dr. Shovita Padhi on the planning of vaccination sites across the City of Toronto. To submit questions about vaccine planning and distribution, please click here. To join the meeting at the time of the event, please click here. Watch Scarborough-Guildwood’s past Live Town Hall meetings on my YouTube channel - like and subscribe for more videos! Ensure you Subscribe to the channel! The City of Toronto remains subject to a provincial wide Stay-at-Home order. The provincial wide shutdown requires all residents to remain home except for essential purposes. I encourage everyone to review the Province's COVID-19 public health measures and advice, the City’s Guide for Toronto Residents and Changes to City Services for the most up-to-date information on public health guidelines and regulations. Where to get accurate COVID-19 vaccine information There is a lot of incorrect information about the COVID-19 vaccines on social media and group chats, such as WhatsApp. Accurate and trusted information can be found on the City’s COVID- 19: Vaccines webpage. If you have questions about the vaccines, you should speak with your doctor or health care provider.
    [Show full text]
  • May 20, 2021 Update Dear Neighbours, I Would Like To
    May 20, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. *NEW* Today, the Ontario government released its three-step Roadmap to Safely Reopen the Province. Roadmap to Reopen outlines three steps to easing public health measures, guided by the following principles: • Step One An initial focus on resuming outdoor activities with smaller crowds where the risk of transmission is lower, and permitting retail with restrictions. This includes allowing outdoor gatherings of up to 10 people, outdoor dining with up to four people per table and non-essential retail at 15 per cent capacity. • Step Two Further expanding outdoor activities and resuming limited indoor services with small numbers of people where face coverings are worn. This includes outdoor gatherings of up to 25 people, outdoor sports and leagues, overnight camps, personal care services where face coverings can be worn and with capacity limits, as well as indoor religious services, rites or ceremony gatherings at 15 per cent capacity. • Step Three Expanding access to indoor settings, with restrictions, including where there are larger numbers of people and where face coverings can’t always be worn. This includes indoor sports and recreational fitness; indoor dining, museums, art galleries and libraries, and casinos and bingo halls, with capacity limits.
    [Show full text]
  • Debates of the House of Commons
    43rd PARLIAMENT, 2nd SESSION House of Commons Debates Official Report (Hansard) Volume 150 No. 083 Monday, April 19, 2021 Speaker: The Honourable Anthony Rota CONTENTS (Table of Contents appears at back of this issue.) 5773 HOUSE OF COMMONS Monday, April 19, 2021 The House met at 11 a.m. members to be mindful of their words, which may be heard by oth‐ er members and by many Canadians as being offensive. ● (1105) Prayer The Speaker: I want to thank the hon. member for his point of order. I take it under advisement. I will return to the House with a ● (1100) ruling on that. [English] POINTS OF ORDER PRIVATE MEMBERS' BUSINESS COMMENTS BY THE MEMBER FOR CLOVERDALE—LANGLEY CITY [Translation] Mr. Robert Oliphant (Parliamentary Secretary to the Minis‐ ter of Foreign Affairs, Lib.): Mr. Speaker, I rise on a point of or‐ EMPLOYMENT INSURANCE ACT der. Mrs. Claude DeBellefeuille (Salaberry—Suroît, BQ) moved On Friday, April 16, at the last sitting of this House, we had de‐ that Bill C-265, An Act to amend the Employment Insurance Act bate on Bill C-6, an act to amend the Criminal Code, conversion (illness, injury or quarantine), be read the second time and referred therapy. During the question-and-answer period following my to a committee. speech opening the morning's debate, contrary to Standing Order She said: Mr. Speaker, this is it. We made it. It is finally time to 18, the member for Cloverdale—Langley City used language that debate a very compassionate, common-sense bill that seeks to ex‐ was offensive to me and, in my understanding, to many other mem‐ tend special employment insurance sickness benefits from bers of the House.
    [Show full text]
  • Horizon Scanning Status Report December 2020
    PCORI Health Care Horizon Scanning System Volume 2 Issue 4 Horizon Scanning Status Report December 2020 Prepared for: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036 Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12 Prepared by: ECRI Institute 5200 Butler Pike Plymouth Meeting, PA 19462 Investigators: Randy Hulshizer, MA, MS Damian Carlson, MS Christian Cuevas, PhD Andrea Druga, MSPAS, PA-C Marcus Lynch, PhD, MBA Misha Mehta, MS Prital Patel, MPH Brian Wilkinson, MA Donna Beales, MLIS Jennifer De Lurio, MS Eloise DeHaan, BS Eileen Erinoff, MSLIS Cassia Hulshizer, BBA Madison Kimball, MS Maria Middleton, MPH Melinda Rossi, BS Diane Robertson, BA Kelley Tipton, MPH Rosemary Walker, MLIS Andrew Furman, MD, MMM, FACEP Statement of Funding and Purpose This report incorporates data collected during implementation of the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System, operated by ECRI under contract to PCORI, Washington, DC (Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12). The findings and conclusions in this document are those of the authors, who are responsible for its content. No statement in this report should be construed as an official position of PCORI. An intervention that potentially meets inclusion criteria might not appear in this report simply because the Horizon Scanning System has not yet detected it or it does not yet meet the inclusion criteria outlined in the PCORI Health Care Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Inclusion or absence of interventions in the horizon scanning reports will change over time as new information is collected; therefore, inclusion or absence should not be construed as either an endorsement or a rejection of specific interventions.
    [Show full text]
  • The Innovation Awards 2020
    DECEMBER 2020 # 71 In My View Feature Best Practice NextGen The benefits of 3D printing How far have we come Top tips for E&L Reviewing setbacks and for biopharma against COVID-19? analysis successes in gene therapy 10 24 – 31 36 – 39 46 – 49 The Innovation Awards 2020 Celebrating 2020’s top pharma development and manufacturing technologies 14 – 21 www.themedicinemaker.com Do You Want to Learn More About monoclonal Antibody Production? Today’s bioprocess professionals need to stay on top of many things: Scale-up parameters and equipment capabilities, control strategies and automation, validation requirements and docu- mentation to name a few. New fields of applications like stem cell technology are evolving into powerful tools of the future. Become a bioprocessing. Join us at www.eppendorf.com/bioprocess Eppendorf® and the Eppendorf Brand Design are registered trademarks of Eppendorf AG, Germany. www.eppendorf.com /bioprocess All rights reserved, including graphics and images. Copyright © 2020 by Eppendorf AG. Is it Time to Reevaluate Our Priorities? The COVID-19 vaccines demonstrate what’s possible Editorial when disease is tackled as a genuine priority he whole research and development community is working hard to bring us that [COVID-19] breakthrough sooner rather than later,” wrote TStephanie Sutton in her November editorial (1). And here we are, just one month later, with not one but three breakthroughs. Pfizer (2) and Moderna (3) are both claiming around 95 percent efficacy in their vaccine studies, involving 44,000 and 30,000 volunteers respectively. And then we had AstraZeneca and the University of Oxford announcing that their vaccine, which should be cheaper and easier to distribute than the aforementioned mRNA approaches, is 70 percent effective (4).
    [Show full text]
  • COVID-19 and the State of Global Mobility in 2020
    COVID-19 and the State of Global Mobility in 2020 Meghan Benton Jeanne Batalova Samuel Davidoff-Gore Timo Schmidt The opinions expressed in the report are those of the authors and do not necessarily reflect the views of the International Organization for Migration (IOM). The designations employed and the presentation of material throughout the report do not imply expression of any opinion whatsoever on the part of IOM concerning legal status of any country, territory, city or area, or of its authorities, or concerning its frontiers or boundaries. IOM is committed to the principle that humane and orderly migration benefits migrants and society. As an intergovernmental organization, IOM acts with its partners in the international community to: assist in meeting the operational challenges of migration; advance understanding of migration issues; encourage social and economic development through migration; and uphold the human dignity and well-being of migrants. The Migration Policy Institute (MPI) is an independent, nonpartisan think tank that seeks to improve immigration and integration policies through authoritative research and analysis, opportunities for learning and dialogue, and the development of new ideas to address complex policy questions. MPI is an independent, nonpartisan policy research organization that adheres to the highest standard of rigor and integrity in its work. All analysis, recommendations and policy ideas advanced by MPI are solely determined by its researchers. This publication was made possible through support provided by the German Federal Foreign Office. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the German Federal Foreign Office. Publisher: International Organization for Migration Publisher: Migration Policy Institute 17 Route des Morillons 1400 16th St NW P.O.
    [Show full text]
  • Downloaded Or Used a Contact Tracing/Exposure Notification App (77%) and Who Would Not Receive a COVID-19 Vaccine When Available (20%) Or Were Unsure (12%)
    COVID-19 Evidence Support Team EVIDENCE SEARCH REPORT Review Question: How effective are COVID-19 vaccines? Context: Benefits following dose/second dose; how well it prevents infections; evidence of limiting viral replication or spread; preventing hospitalization; preventing ventilation; preventing “long COVID” (long term symptoms), duration of immunity (natural and vaccinated). FDA cold chain changes. Effectiveness against P1 variant. Booster doses for variants. Does not include vaccine willingness/acceptance (to be run as a separate search) Review Code: INF031801v3 ESR Complete Date: April 30, 2021 Cite As: Miller, L., Howell-Spooner, B.. How effective are COVID-19 vaccines? 2021 Apr 30, Document no.: INF031801v3 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 107 p. (CEST evidence search report). Librarian Notes & Comments Hello All, We’ve run this update for the databases from March 18th to April 30th, and searched for grey literature between those dates as well. Thanks, Brianna and Lukas Search Results: Guidelines, Summaries & Other Grey Literature Government Health Canada Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply. April 14, 2021. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee- on-immunization-naci/extended-dose-intervals-covid-19-vaccines-early-rollout-population- protection.html Public Health Agency of Canada Disclaimer This information is provided as a service by the Saskatchewan Health Authority and University of Saskatchewan Libraries. Professional librarians conduct searches of the literature. Results are subject to the limitations of the databases and the specificity, broadness and appropriateness of the search parameters presented by the requester.
    [Show full text]
  • Non-Viral COVID-19 Vaccine Delivery Systems
    Advanced Drug Delivery Reviews 169 (2021) 137–151 Contents lists available at ScienceDirect Advanced Drug Delivery Reviews journal homepage: www.elsevier.com/locate/addr Non-viral COVID-19 vaccine delivery systems Kyung Soo Park a,b,1, Xiaoqi Sun b,c,1, Marisa E. Aikins b,c,1, James J. Moon a,b,c,⁎ a Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA b Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA c Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA article info abstract Article history: The novel corona virus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread Received 10 October 2020 throughout the globe at a formidable speed, causing tens of millions of cases and more than one million deaths Received in revised form 20 November 2020 in less than a year of its report in December 2019. Since then, companies and research institutions have raced Accepted 13 December 2020 to develop SARS-CoV-2 vaccines, ranging from conventional viral and protein-based vaccines to those that are Available online 17 December 2020 more cutting edge, including DNA- and mRNA-based vaccines. Each vaccine exhibits a different potency and du- ration of efficacy, as determined by the antigen design, adjuvant molecules, vaccine delivery platforms, and im- munization method. In this review, we will introduce a few of the leading non-viral vaccines that are under clinical stage development and discuss delivery strategies to improve vaccine efficacy, duration of protection, safety, and mass vaccination. ©2020ElsevierB.V.Allrightsreserved.
    [Show full text]
  • Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
    COVID-19 Treatment Guidelines Coronavirus Disease 2019 (COVID-19) Treatment Guidelines Credit NIAID-RML Downloaded from https://www.covid19treatmentguidelines.nih.gov/ on 9/25/2021 Visit https://www.covid19treatmentguidelines.nih.gov/ to access the most up-to-date guideline. How to Cite the COVID-19 Treatment Guidelines: COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed [insert date]. The COVID-19 Treatment Guidelines Panel regularly updates the recommendations in these guidelines as new information on the management of COVID-19 becomes available. The most recent version of the guidelines can be found on the COVID-19 Treatment Guidelines website (https://www.covid19treatmentguidelines.nih.gov/). Downloaded from https://www.covid19treatmentguidelines.nih.gov/ on 9/25/2021 Table of Contents What’s New in the Guidelines .................................................................................................. 5 The COVID-19 Treatment Guidelines Panel’s Statement on Bamlanivimab Plus Etesevimab for the Treatment of Mild to Moderate COVID-19 in Nonhospitalized Patients ..... 8 The COVID-19 Treatment Guidelines Panel’s Statement on the Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection When There Are Logistical Constraints ...................................................................... 9 The COVID-19 Treatment Guidelines
    [Show full text]